S-1 and oxaliplatin versus tegafur-uracil and leucovorin as post-operative adjuvant chemotherapy in patients with high-risk stage III colon cancer: updated 5-year survival of the phase III ACTS-CC 02 trial.
Watanabe J, Sasaki S, Kusumoto T, Sakamoto Y, Yoshida K, Tomita N, Maeda A, Teshima J, Yokota M, Tanaka C, Yamauchi J, Uetake H, Itabashi M, Takahashi K, Baba H, Kotake K, Boku N, Aiba K, Morita S, Takenaka N, Sugihara K.
Watanabe J, et al. Among authors: yokota m.
ESMO Open. 2021 Apr;6(2):100077. doi: 10.1016/j.esmoop.2021.100077. Epub 2021 Mar 11.
ESMO Open. 2021.
PMID: 33714860
Free PMC article.
Clinical Trial.